Mechanistically, ALKBH5 inhibits ACC1 deacetylation by promoting SIRT3 methylation, and the resulting downregulation of ACC1 expression ultimately inhibits tumor growth, lipid metabolism, and tumorigenesis (94). Here, ALKBH5 is linked to neoplasm.